Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator
2022 · European Journal of Medicinal Chemistry Reports · 3 citations
https://doi.org/10.1016/j.ejmcr.2022.100097
M
Mohammed Mukhtar Yusif
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Mohammed Mukhtar Yusif is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat